#1 · 226950
OliX Pharmaceuticals, Inc.9.86%
Close
₩6,445
Net assets
₩4.5B
Trading value
₩58M
Premium/discount
+0.57%
Compare MIGHTY New Drug Focus Bio Active (0229F0) holdings, returns, price versus NAV and estimated fund flows. See each data date on the page.
Returns are negative over every period shown. The premium/discount is within 1%.
1D
-7.27%
5D
-6.66%
20D
-23.46%
60D
—
YTD
—
1Y
—
Estimated creations/redemptionsLast 60 sessions
2 of the last 37 sessions (5%) saw net inflows and 2 saw net outflows.
1D
—
20D
₩0
60D
-₩959M
View daily fund flows
| Date | Estimated net flow |
|---|---|
| 2026-11-06 | — |
| 2026-11-05 | — |
| 2026-11-04 | — |
| 2026-11-03 | — |
| 2026-11-02 | — |
| 2026-10-30 | — |
| 2026-10-29 | ₩0 |
| 2026-10-28 | ₩0 |
| 2026-10-27 | ₩0 |
| 2026-10-26 | ₩0 |
| 2026-10-23 | ₩0 |
| 2026-10-22 | ₩0 |
| 2026-10-21 | ₩0 |
| 2026-10-20 | ₩0 |
| 2026-10-19 | ₩0 |
| 2026-10-16 | — |
| 2026-10-15 | ₩0 |
| 2026-10-14 | ₩0 |
| 2026-10-13 | ₩0 |
| 2026-10-12 | ₩0 |
| 2026-10-08 | +₩417M |
| 2026-10-07 | ₩0 |
| 2026-10-06 | ₩0 |
| 2026-10-02 | ₩0 |
| 2026-10-01 | -₩442M |
| 2026-09-30 | ₩0 |
| 2026-09-29 | ₩0 |
| 2026-09-28 | ₩0 |
| 2026-09-23 | ₩0 |
| 2026-09-22 | ₩0 |
| 2026-09-21 | ₩0 |
| 2026-09-18 | ₩0 |
| 2026-09-17 | ₩0 |
| 2026-09-16 | ₩0 |
| 2026-09-15 | ₩0 |
| 2026-09-14 | ₩0 |
| 2026-09-11 | ₩0 |
| 2026-09-10 | +₩442M |
| 2026-09-09 | ₩0 |
| 2026-09-08 | ₩0 |
| 2026-09-07 | -₩1.4B |
| 2026-09-04 | ₩0 |
| 2026-09-03 | ₩0 |
| 2026-09-02 | ₩0 |
| 2026-09-01 | — |
Estimated as change in listed units × current NAV
Holdings and weightsHoldings date 26-10-30 · 18 holdings · 100.0%
The top 5 holdings make up 42.8% of the fund, and the top 10 71.7%.
| # | Holding | Weight | Status |
|---|---|---|---|
| 1 | OliX Pharmaceuticals, Inc. 226950 | 9.86% | |
| 2 | OSCOTECInc. 039200 | 9.68% | |
| 3 | Alteogen Inc. 196170 | 8.31% | |
| 4 | Samyang Biopharm Corporation 0120G0 | 7.46% | |
| 5 | Rznomics Inc. 476830 | 7.44% | |
| 6 | ST PHARM CO., LTD. 237690 | 6.18% | |
| 7 | LigaChem Biosciences Inc. 141080 | 5.88% | |
| 8 | ABL Bio Inc. 298380 | 5.80% | |
| 9 | AbClon Inc. 174900 | 5.65% | |
| 10 | HANALL BIOPHARMA CO.,LTD 009420 | 5.47% | |
| 11 | G2GBIO, Inc. 456160 | 5.03% | |
| 12 | GI Innovation Inc. 358570 | 4.54% | |
| 13 | Qurient Co., Ltd. 115180 | 4.42% | |
| 14 | HLB innoVation Co.,Ltd. 024850 | 4.13% | |
| 15 | Voronoi, Inc. 310210 | 3.71% | |
| 16 | Y-Biologics, Inc 338840 | 2.85% | |
| 17 | D&D Pharmatech Inc. 347850 | 2.62% | |
| 18 | KRW Cash 010010 | 0.97% |
#2 · 039200
OSCOTECInc.9.68%
#3 · 196170
Alteogen Inc.8.31%
#4 · 0120G0
Samyang Biopharm Corporation
7.46%
#5 · 476830
Rznomics Inc.7.44%
#6 · 237690
ST PHARM CO., LTD.6.18%
#7 · 141080
LigaChem Biosciences Inc.5.88%
#8 · 298380
ABL Bio Inc.5.80%
#9 · 174900
AbClon Inc.
5.65%
#10 · 009420
HANALL BIOPHARMA CO.,LTD5.47%
#11 · 456160
G2GBIO, Inc.
5.03%
#12 · 358570
GI Innovation Inc.
4.54%
#13 · 115180
Qurient Co., Ltd.
4.42%
#14 · 024850
HLB innoVation Co.,Ltd.
4.13%
#15 · 310210
Voronoi, Inc.
3.71%
#16 · 338840
Y-Biologics, Inc
2.85%
#17 · 347850
D&D Pharmatech Inc.2.62%
#18 · 010010
KRW Cash
0.97%